Bluejay Diagnostics (BJDX) Interest Coverage Ratio (2024 - 2025)
Bluejay Diagnostics recorded quarterly Interest Coverage Ratio of 7816.83 in Q4 2025, up 3.31% quarter-over-quarter from 8084.74 in Q3 2025, and down 283.83% year-over-year from 4252.27 in Q4 2024.
Bluejay Diagnostics' Interest Coverage Ratio history runs 2 years deep, the most recent figure standing at 7816.83 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio fell 283.83% year-over-year to 7816.83; the TTM figure through Mar 2026 stood at 11498.99 (down 141730.8% YoY), while the FY2025 annual figure was 8287.21, down 95032.13% from the prior year.
- Interest Coverage Ratio came in at 7816.83 for Q4 2025 at Bluejay Diagnostics, up from 8084.74 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 3.03 in Q2 2024 to a low of 8943.07 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.73 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.09 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.23 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -2.90 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.36 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 20.98 |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7,816.83 |
| Sep 30, 2025 | -8,084.74 |
| Jun 30, 2025 | -8,943.07 |
| Dec 31, 2024 | -2,036.55 |
| Sep 30, 2024 | -7.14 |
| Jun 30, 2024 | -3.03 |